Cerebral protection during transcatheter aortic valve implantation in an extreme high-risk patient

Stephanie Voss1, Christian Nöbauer1, Rüdiger Lange1

  • 1Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, Munich, Germany.

Insights

Cerebral protection devices during transcatheter aortic valve replacement may prevent stroke. A dual filter device captured debris, and the patient experienced no post-procedure neurological deficits.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Stroke is a significant complication of transcatheter aortic valve replacement (TAVR).
  • Cerebral embolization of debris during TAVR poses a risk for cerebrovascular accidents.
  • Advanced technologies are emerging to mitigate embolic events during TAVR.

Observation:

  • A high-risk 78-year-old patient with severe calcific aortic stenosis underwent TAVR.
  • The patient was protected using the dual filter-based Claret Sentinel™ Cerebral Protection Device.
  • The Sentinel Device was observed to capture macroscopic debris during the procedure.

Findings:

  • The Claret Sentinel Device successfully captured embolic material during TAVR.
  • Post-procedure neurological assessment revealed no deficits using the National Institutes of Health Stroke Scale and modified Rankin scale.
  • This suggests the device's efficacy in preventing stroke during TAVR.

Implications:

  • Cerebral protection devices may reduce the incidence of stroke in TAVR patients.
  • The Sentinel Device offers a potential strategy for preventing neurological complications in high-risk TAVR candidates.
  • Further research should explore the widespread adoption and long-term benefits of cerebral protection during TAVR.